(1) THE BEGINNING OF THE VIRAL TESTING AND THE NECESSITY OF RECONSIDERATION OF THE COLPOSCOPICAL IMAGES IN THE HPV CERVICAL INFECTIONS
Assoc. Prof. Ana - Cristina Anton, M.D., Ph.D.; Demetra Socolov, M.D.; Mihaela Grigore, M.D.; Irina Ciupilan, M.D.
Gr. T Popa" University of Medicine - Iasi, Romania

(2) THE HPV INFECTION IN THE CERVICAL NEOPLASIA IN NORTH - EAST ROMANIA
Gabriela Anton, Ph.D.*; Assoc. Prof. Ana - Cristina Anton, M.D., Ph.D.**, Demetra Socolov, M.D.*; Rodica Repanovici, Ph.D.*
*"Stefan S. Nicolau" Institute of Virology - Bucharest; **"Gr. T Popa" University of Medicine - Iasi, Romania

(3) META-ANALYSIS OF THE DIAGNOSTIC PROPERTIES OF RAPID (RE-) SCREENING OF PAP SMEARS
Marc Arbyn, M.D., MSc,¹ Ulrich Schenck, M.D., FIAC^2
1Scientific Institute of Public Health, Brussels, Belgium; ²Zytologisches Institut der Bayerischen Krebsgesellschaft, Munich, Germany

(4) SHANXI PROVINCE CERVICAL CANCER SCREENING STUDY: A CROSS-SECTIONAL COMPARATIVE TRIAL OF MULTIPLE TECHNIQUES TO DETECT CERVICAL INTRAEPITHELIAL NEOPLASIA
J. Belinson¹, Y. Qiao², R. Pretorius³, W. Zhang², P. Elson¹, K. Keaton², A. Lorincz⁴, Q. Pan², L. Li², C. Biscotti¹, A. Dawson¹, A. Lee², L. Wu²
The Departments of Gynecology, Pathology and Biostatistics from ¹The Cleveland Clinic Foundation, Cleveland Ohio, ²The Cancer/Institute Hospital Chinese Academy of Medical Sciences, Beijing China, ³Department of Gynecologic Oncology and Pelvic Surgery, Kaiser Permanente, Fontana, California. ⁴Digene Corporation, Silver Spring, Maryland, USA

(5) Cyclin E Expression as a Marker for Early Cervical Neoplasia
Marluce Bibbo M.D., Albert J. Kovatich, MS, Eric J. Weaver, M.D.
Jefferson Medical College, Philadelphia, Pennsylvania, USA

(6) Computer-aided analysis of cervical cytology images using a three dimensional color model
Beth Bjerregaard M.D., PH.D.*, Jan Jantzen MSC PH.D.**, Thomas Hasselager M.D.*, Pia Kopke*, Susan Wann-Larsen*
*Department of Pathology, Herlev University Hospital, Copenhagen, Herlev, **Department of Automation, Technical University, Copenhagen, Herlev, Denmark.

(7) IMPROVING THE PERFORMANCE OF CERVICAL CANCER SCREENING THROUGH VISUAL INSPECTION AND ADJUNCTIVE HPV TESTING
Paul Blumenthal, M.D., MPH¹, Lynne Gaffikin, DrPH¹, Mike Chirenje, M.D.², Tsungai Chipato, M.D.², Harare Zimabwe³, John McGrath, MA³, Keerti Shah, Ph.D.⁴, Sharita Womack, Ph.D. ^4
1JHPIEGO, Johns Hopkins University, Baltimore, Maryland, USA, ²University of Zimbabwe, ³JHPIEGO, University of Zimbabwe, ⁴Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland, USA

(8) a manual method for AutoCyte PREPÒ Cervico-vaginal Samples
Charles Carrico, BA, James W. Geyer, Ph.D., John W. Bishop, M.D.
TriPath Imaging Inc., Burlington, North Carolina and University of California Davis, Davis, California, USA

(9) CERVICAL SCREENING-CHALLENGES IN A DEVELOPING WORLD
Akhtar S. Chughtai, M.D., MIAC, Itrat Ahmed, MBBS, Mphil, MIAC
Chughtais Lahore Limited, Ammar Medical Complex, Lahore, Pakistan

(10) QUALITY CONTROL IN CERVICAL CANCER PROGRAM OF PARANA – BRAZIL
L.M. Collaço, F. Medeiros, A. Sobral, J.T. Totsugui, S.R. Araújo, B. Werner, L.F. Bleggi-Torres
Hospital de Clínicas - Universidade Federal do Paraná, Curitiba, Brazil

(11) EVALUATION OF AN ALTERNATIVE SPECULUM FOR RETRIEVAL OF CERVICAL CELLS
R.A. Conlen, M.D., FACOG*, A.A. Hurley, Ph.D.**
*Boca Raton Obstetric and Gynecology, Boca Raton, Florida, **Comprehensive Cytometric Consulting. Hanover, Massachusetts, USA

(12) Boundaries and Mutual Exclusivity in The Bethesda System
Stewart F, Cramer M.D.
Department of Pathology, Rochester General Hospital, Rochester, New York, USA

(13) Visual Inspection With Acetic Acid (VIA), an Alternative Screening Method for cervical dysplasia and cancer?
Dr. Hugo De Vuyst¹, Dr. Samuel Njiru², Dr. Patricia Claeys³, Prof. Dr. Marleen Temmerman^3
1Department of Medicine Microbiology, University of Nairobi/University of Ghent, Nairobi, Kenya/Ghent, Belgium, ²Department of Medicine Microbiology, University of Nairobi, Nairobi, Kenya, ³Department of Obstetrics & Gynecology, ICRH, University of Ghent, Ghent, Belgium

(14) CERVICAL CARCINOMA IN SOUTHERN TURKEY
Canan Ersöz, Prof. M.I.A.C.¹, M. Ali Vardar, Assoc. Prof.², Aysun Uguz, M.D.¹
Departments of ¹Pathology and ²Gynecology and Obstetrics, Çukurova University Medical Faculty, Adana, Turkey

(15) the impact of Stage IA disease in the increased incidence of cervical cancer in slovenia
Mojca Erzen, M.D., Ph.D., Jule Kova¹ i¹ , M.D., Ph.D.
Department of Obstetrics and Gynecology, Unit of Gynecological Cytology and Pathology, Ljubljana, Slovenia

(16) DETERMINATION OF THE PREDICTIVE VALUE OF BORDERLINE NUCLEAR CHANGE AND MILD DYSKARYOSIS IN A POPULATION SCREENING PROGRAM
A. Etteridge, E.M. Hewer*, FIBMS, CTIAC(Gyn), S. Rice* BSc, K. Snee, M.Sc., FIBMS, J.H.F.Smith, MB, BS, FRCPath
Department of Histopathology and Cytology and *Trent Region Cervical Screening Program Quality Assurance Reference Centre, Northern General Hospital, Sheffield. UK.

(17) LEEP DIAGNOSTICS
Alex Ferenczy, M.D.
Professor of Pathology and Obstetrics & Gynecology, McGill University, Montreal, Quebec, Canada

(18) SCREENING FOR CANCER – WHAT IS THE GOAL?
David Garner, Ph.D.
Senior Scientist, Cancer Imaging, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

(19) CELLULAR CONSTITUTION OF AUTOCYTE PREPâ CERVICOVAGINAL SAMPLES WITH BIOPSY CONFIRMED HSIL
James W. Geyer, Ph.D.,¹ Charles Carrico, B.A.,¹ John W. Bishop, M.D.^2
1TriPath Imaging Inc., Burlington, North Carolina, ²University of California, Davis Medical Center, Sacramento, California, USA

(20) A NOVEL DEVICE FOR COLLECTION OF CERVICAL CELLS
George I. Gorodeski, M.D., Ph.D.
CWRU School of Medicine, Cleveland Ohio; and Ampersand LLC, Chicago Illinois, USA

(21) Digital Microscopy for Multiparameter FISH Imaging
H. Gundlach
Carl Zeiss, Oberkochen, Germany

(22) HOSPITAL BASED CERVICAL CYTOLOGY: LOCAL EXPERIENCE
S.K. Gupta, M.D, MIAC, P. Dey, M.D, MIAC, R. Nijhawan, M.D., S. Radhika, M.D., Ph.D., H. Sawhney, M.D.
Departments of Cytology & Gynecological Histopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, INDIA.

(23) QUALITY ASSURANCE IN CIN-MANAGEMENT (Guidelines of GSCPC)
Prof.Dr. Jürgen Heinrich
Department Obstetrics & Gynecology, Klinikum, Stralsund, Germany

(24) CERVICAL SCREENING IN ENGLAND AND WALES BEFORE THERE WAS AN ORGANIZED PROGRAM
Amanda Herbert, MB, BS, FRCPath
Histopathology Department, Guy’s and St. Thomas’ Hospitals Trust, London, England, UK

(25) CLINICAL EXPERIENCE AND SENSITIVITY OF THE AUTOPAP 300 QC SYSTEM IN CERVICOVAGINAL CYTOLOGY
Sung Ran Hong, M.D., Jong Sook Park, CMIAC, Hoi Sook Jang, CMIAC, Yee Jeong Kim, M.D., Hy Sook Kim, M.D., Chong Taik Park*, M.D., In Sou Park*, M.D.
Departments of Pathology and Obstetrics and *Gynecology, Samsung Cheil Hospital, Sungkyunkwan University School of Medicine, Chung-ku, Seoul, Korea

(26) ESTABLISHMENT DE NOVO AND COST-EFFECTIVENESS OF PAP SMEAR SCREENING SERVICES IN A LARGE DEVELOPING COUNTRY
Nguyen Chan Hung¹, Pham Nhu The², Nguyen Ba Duc³, Stephen S. Raab⁴, Eric J. Suba^5
1Ho Chi Minh City Cancer Center, Ho Chi Minh, ²Hue Regional Medical Center, Hue, ³K Hospital/National Cancer Institute, Hanoi, Vietnam, ⁴Kaiser Permanente Medical Center, Redwood City, CA; Allegheny General Hospital, Pittsburgh, Pennsylvania, ⁵The Viet/American Cervical Cancer Prevention Project, San Francisco, California, USA

(27) HYBRID CAPTURE II AS A SCREENING TOOL FOR CERVICAL CANCER IN DEVELOPING COUNTRIES: THE CHICOANA-SALTA-ARGENTINA PROJECT.
L.T. Illescas,¹ A.T. Lorincz,² C.P. Schere,¹ N. Dain,¹ A. Dino,¹ D. Lonegro,³ V. Molina,³ M. Pico,¹ R. Laudi,¹ A.V. Arrossi,¹ O. Ithurralde,¹ L. Carrizo,³ G.B. Dores,^4
1Instituto Papanicolaou, Buenos Aires, Argentina; ²Digene Corporation, Gaithersburg Maryland, USA; ³Hospital Dr. Rafael Villagrán, Chicoana, Salta, Argentina; ⁴Digene Corporation, Brazil

(28) HPV DNA HYBRID CAPTURE TEST AS A POTENTIAL SCREENING TOOL IN POSTMENOPAUSAL WOMEN
L.T. Illescas,¹ A.T. Lorincz,² C.P. Schere,¹ R. Laudi,¹ A.V. Arrossi,¹ O. Ithurralde,¹ D. Lonegro,³ V. Molina,^3
1Instituto Papanicolaou, Buenos Aires, Argentina. ²Digene Corporation, Gaithersburg, Maryland, USA, ³Hospital R. Villagrán, Chicoana, Salta, Argentina.

(29) TRENDS OF CERVICAL NEOPLASIA IN YOUNG WOMEN
Elmar A. Joura, M.D., Jeanette Klimont, BA
Department of Gynecology, University of Vienna, Österreichisches Statistisches Zentralamt (National Cancer Register), Vienna, Austria

(30) PHYSICAL STATE OF HPV 16, AND CHROMOSOMAL MAPPING OF THE INTEGRATED FORM IN CERVICAL CARCINOMAS
Mina Kalantari, Elisabeth Blennow, Bjørn Hagmar, Bo Johansson
Division of Clinical Virology, Huddinge University Hospital, Department of Molecular Medicine, Karolinska Institut, Stockholm, Sweden, Department of Pathology, The National University Hospital, Oslo, Norway

(31) Complicated way lowering ca cervix incidence
J. Kobilková,* B. Pazderník, J. Dušková**
*Department of Gynecology, **Institute of Pathology, Ist Medical Faculty, Prague, Czech Republic

(32) Significance of "smudgy" nuclear appearance associated with human papillomavirus 16/18 types infection
Shuichi Kohri, CT(IAC), B.Sc., Masahiko Fujii, MIAC, Ph.D., Mizue Oda, M.D., Tomoko Takeda, M.D., Yataro Yanagisawa, M.D., Mineo Ohmura, M.D., Ph.D., Yoshio Shiina, CFIAC, Ph.D.
Kyorin University, Hachioji, Tokyo, Japan

(33) PATTERNS OF CERVICAL CANCER SCREENING IN THE GREEK POPULATION
H. Koutselini, M.D., FIAC, H. Symiakaki, M.D., M. Papaefthimiou, M.D., Ch. Deftereos, M.D., D. Alexopoulou, M.D., A. Terpos, M.D., A. Limos, M.D.
Aretaieio University Hospital, Alexandra Maternity Hospital and Evangelismos General Hospital, Athens, Greece.

(34) EPIDEMIOLOGY OF CARCINOMA CERVIX IN SRI LANKA
Priyanthi Kumarasinghe M.D., FRCPA, Mali Fernando, M.D.
Department of Pathology, Faculty of Medicine , University of Colombo, Nawala, Sri Lanka

(35) PREVALENCE OF ABNORMAL CERVICAL SMEARS IN WOMEN ATTENDING A GENERAL GYNECOLOGY CLINIC
Priyanthi Kumarasinghe M.D., FRCPA, O.M. Prabath
Department of Pathology, Faculty of Medicine, University of Colombo, Nawala, Sri Lanka

(36) A review of Anti-Cervical Cancer Efforts in the Philippines
Cecilia A. Ladines-Llave, M.D., Ph.D.
Department of Obstetrics and Gynecology UP-PGH, University of the Philippines-Philippine General Hospital, Manila, Philippines

(37) THE NANOSCAN PROJECT: FAST SCANNING AND PARALLEL PROCESSING OF LIGHT MICROSCOPY SPECIMENS
Peter Locht, M.D., Peter Mikkelsen, Knud Thomsen
DIMAC (Digital Image Company), Hojbjerg, Denmark

(38) A NEW MARKER OF PAP SMEAR PATHOLOGY
Olivera Markovic, M.D., Ph.D., Nenad Markovic, M.D., Ph.D.
BioSciCon, Inc., Rockville, Maryland, USA

(39) ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE IN ATROPHIC SMEARS
Maria-Sultana Mihailovici, M.D., Ph.D., MIAC, S. Teleman, M.D., Ph.D., MIAC, Cristina Anton, Ph.D., Demetra Socolov, M.D.
Departments of Pathology and Gynecology of University of Medicine and Pharmacy, "Gr. T. Popa", Iasi, Romania

(40) FOLLOW-UP OF UNSATISFACTORY AND ASCUS/LSIL PAP-SMEARS
Jan F. Nygård, BSc, Torill Sauer, Ph.D., FIAC, Gry B. Skare, BSc,
Steinar Ø. Thoresen, Ph.D., MIAC
The Cancer Registry of Norway, Oslo, Norway

(41) Biomolecular Protein-Specific Cervical Screening
Bruce K. Patterson, M.D., Ph.D.
Children's Memorial Hospital, Chicago, Illinois

(42) DETECTION OF HPV IN SQUAMOUS INTREPITHELIAL LESION (SIL) BY HYBRID CAPTURE II (HCII). CLINICAL AND DIAGNOSTIC IMPACT
J. Ponce, L. Martí, B. Lloveras, I. Catalá, E. Condom, L. Balagueró, X. Cortés.
Ciudad Sanitaria y Universitaria de Bellvitge. Barcelona. Asociación Española de Patología Cervical y Colposcopia (AEPCC). Spain.

(43) THE CYTOLOGY LABORATORY SYSTEM IN CHILE
Rodrigo Prado, M.D., FIAC
Faculty of Medicine, Cytopathology Unit, Chile University, Santiago, Chile

(44) COMPARISON OF TWO HYBRID CAPTURE TESTS FOR HIGH-RISK HUMAN PAPILLOMAVIRUS AT COLPOSCOPY
Robert G. Pretorius, M.D., Pat Peterson, Susan Novak, Ph.D., Faramarz Azizi, M.D., Masood Sadeghi, M.D.
Department Obstetrics and Gynecology, Southern California Permanente Medical Group, Fontana, California, USA

(45) MUCOSAL AND SYSTEMIC IMMUNIZATION WITH BPVLIE/VLP VACCINE INDUCE EFFECTIVE CELLULAR IMMUNITY
Junko Saito, M.D., Ph.D., MIAC,¹ Hideharu Kanzaki, M.D., Ph.D.,¹ Sadamu Noda, M.D., Ph.D., FIAC,² Graham Leggatt, Ph.D.,³ Ian Frazer, M.D., Ph.D.^3
1Department of Obstetrics and Gynecology, Kansai Medical University, Osaka, ²The Osaka Cancer Prevention and Detection Center, Osaka, Japan, ³Center for Immunology and Cancer Research, University of Queensland, Princess Alexandra Hospital, Brisbane, Queensland, Australia

(46) THE TEN YEAR EXPERIENCE OF CERVICAL CANCER SCREENING IN CHILE
Cecilia Sepulveda, M.D., MPH, Rodrigo Prado, M.D., FIAC
Ministry of Health, Regional Office, Metropolitan Area, Santiago, Chile

(47) EPIDEMIOLOGY OF CERVICAL CANCER IN BANGLADESH
Latifa Shamsuddin, T.A. Chowdhuri, Ashrafunnesa, R.M.A. Kabir
Department of Obstetrics and Gynaecology, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka, Bangladesh

(48) CYTOLOGIC DIAGNOSIS OF HPV-RELATED CHANGES IN THE GYNECOLOGIC SAMPLES
N.A. Shapiro, M.D., Ph.D., Sc.D., MIAC, V.A. Yakovleva, V.V. Demkin, T.A. Konysheva, A.I. Kruglova, L.V. Samsonova
Central Clinical Hospital of Russian Railroad Ministry, Institute of Molecular Genetics for Russian Academy of Sciences, Medical Unit #170 for Federal Department "Medbioextrem", Moscow, Russia

(49) ALLIANCE FOR CERVICAL CANCER PREVENTION
Jacqueline Sherris, Ph.D.
Program Advisor, PATH, Seattle, Washington, USA

(50) ORGANIZING OF CYTOLOGIC SCREENING FOR DETECTION OF CERVICAL CANCER IN THE REPUBLIC OF KAZAKSTAN

Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan

(51) HUMAN PAPILLOMAVIRUS INFECTION ASSOCIATED WITH HERPESVIRUS INFECTION (EPSTEIN-BARR AND HUMAN CYTOMEGALOVIRUS) IN CERVICAL DYSPLASIA
Demetra Socolov, M.D*; Gabriela Anton, Ph.D. **; Assoc. Prof. Ana - Cristina Anton, M.D., Ph.D.*; Ruxandra Achim, M.D.**; Sergiu Teleman, M.D. *
*"Stefan S. Nicolau" Institute of Virusology - Bucharest; **"Gr. T. Popa" University of Medicine, Iasi – Romania

(52) LIQUID-BASED CERVICO-VAGINAL "THIN PREP" (CYTYC CORP.) SPECIMENS’ RANGE OF CYTO-DIAGNOSTIC DETECTABILITY
Harry Z. Suprun, M.D., FIAC
Division of Cytopathology, Department of Pathology, HNL, LVH Medical Center, Health Network Labs, Allentown, Pennsylvania, USA

(53) COST-EFFECTIVENESS OF THE CONVENTIONAL PAP TEST WITH A NEW ADJUNCT TO SCREENING FOR CARCINOMA OF THE CERVIX AND ITS PRECURSORS
Lynn Taylor, MPA¹, Sonja Sorensen, MPH¹; Nancy Ray, MS²; Michael Halpern, M.D, PhD¹; Diane Harper, M.D., MPH³, Stewart Lonky, M.D., MBA^4
1MEDTAP International, Inc., Bethesda, Maryland, ²Medicare Payment Advisory Commission, ³Department of Obstetrics and Gynecology, Community and Family Medicine, Dartmouth Medical School, Hanover, New Hampshire, ⁴The Trylon Corporation, Torrance, California, USA

(54) CORRELATION OF COLPOSCOPIC FINDINGS WITH CYTOLOGIC AND HISTOPATHOLOGIC RESULTS IN UTERINE CERVIX
Levent Tutuncu, M.D., Dilaver Demirel, M.D., MIAC, Ercument Mungen, M.D., A. Aktug Ertekin, M.D., A. Rustu Ergur, M.D., Yusuf Z. Yergok, M.D., Chief.
Gülhane Military Medical Academy, Haydarpasa Training Hospital, Departments of Obstetrics & Gynecology and Pathology, Istanbul, Turkey

(55) CORRELATION BETWEEN TUMOR ANGIOGENESIS AND EXPRESSION OF THYMIDINE PHOSPHORYLASE, AND PATIENT OUTCOME IN UTERINE CERVICAL CARCINOMA
Masatsugu Ueda, M.D.,¹ Minoru Ueki, M.D.,¹ Sadamu Noda, M.D.^2
1Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, and ²Osaka Cancer Prevention Center, Osaka, Japan

(56) COLPOSCOPICAL FEATURE OF CERVICAL ADENOCARCIMA
Minoru Ueki, M.D. ¹, Masatsugu Ueda, M.D. ¹, Sadamu Noda, M.D. ^2
1Department of Obstetrics and Gynecology, Osaka Medical College, Osaka, and ²Osaka Cancer Prevention Center, Osaka, Japan

(57) PRACTICAL APPLICATION OF AUTOPAP SYSTEM TO RESCREENING OF GYNECOLOGICAL SAMPLES FOR QUALITY CONTROL
Kisaburo Ueno, CT(IAC), Noboru Tanaka, M.D., DDS, FIAC, Kyoko Hasebe, CT(IAC), Shigenori Ohtsuka, CT(IAC), Atsushi Kayukawa, Hiroshi Nishida
Pathology and Cytology Center, Biomedical Laboratories, Tokyo, Japan

(58) SCREENING FOR CERVICAL CANCER IN GREECE: PRESENT SITUATION-FUTURE PERSPECTIVES
Smaragda Zachariadou-Veneti, M.D., MIAC
LITO Hospital for Women, Athens, Greece

(59) COMPARISON OF AUTOCYTE PREP WITH CONVENTIONAL PAP SMEAR IN CERVICAL CANCER SCREENING
Alain Verhest, M.D., FIAC, Gilbert Querteon, BMA, Isabelle Fayt, CT, Jean-Christophe Noel, M.D., MIAC
Institut Jules Bordet & Hopital Universitaire Erasme, Université Libre de Bruxelles - Belgium

(60) SENSITIVITY OF THE AUTOPAP SYSTEM USED AS A PRIMARY SCREENING
Paul T. Wertlake, M.D.
Unilab Corporation, Tarzana, California, USA

(61) APPLICATION OF THE COX MODEL IN THE ANALYSIS OF GYNECOLOGIC TUMORS

Feng Xin, Zhang Ying
Municipal Cancer Hospital of Guangzhou, Guangzhou, People’s Republic of China

(62) A Founder for China Fight Against Cervical Cancer
Zhang Ying, M.D., MCSP
Department of Pathology, The 3^rd Affiliated Hospital, Medical College of Jinan University, Zhuhai, Guangdong, People’s Republic of China

(63) TELECYTOLOGY IN CHINA
Zhang Ying, M.D., MCSP
Department of Pathology, The 3^rd Affiliated Hospital, Medical College of Jinan University, Zhuhai, Guangdong, People’s Republic of China

Home Page - Letter of Invitation
Preface by Dr. Bodo (UICC) - Preface by Dr. Solomon (ASC) - Preface by Dr. Vooijs (EFCS/QUATE)
Scientific Directors - Program Steering Committee - Scientific Advisory Committee - Task Force & Program Committee
Conference Details - Program - Important Dates - Conference Venue
Accepted Abstracts - Registration Form - Hotel Room Reservation Form